Cytotoxic T lymphocyte activation by cross-priming

Current Opinion in Immunology

Volumn 11, Issue 3, 1999, Pages 314-318

  Heath, William R ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN;

ANTIGEN PRESENTING CELL; BONE MARROW; CELL INTERACTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; MOLECULAR INTERACTION; NONHUMAN; SHORT SURVEY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0033061017     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80050-8     Document Type: Article

References (4)

1. Bevan MJ: Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J Immunol 1976, 117:2233-2238.
2. Bevan MJ: Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 1976, 143:1283-1288.
3. Kurts C, Heath WR, Carbone FR, Allison J, Miller JFAP, Kosaka H: Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996, 184:923-930.
4. Adler AJ, Marsh DW, Yochum GS, Guzzo JL, Nigam A, Nelson WG, Pardoll DM: CD4+ T cell tolerance to parenchymal self antigens requires presentation by bone marrow derived antigen presenting cells. J Exp Med 1998, 187:1555-1564.